StockData
Amgen Inc logo

Amgen Inc

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$465.45−0.56 (-0.12%)

Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%

Amgen U.S. Federal Statutory Income Tax Rate by Year

U.S. Federal Statutory Income Tax Rate (%) (%)

Amgen U.S. Federal Statutory Income Tax Rate: 21.0% in FY2025, unchanged from a year earlier. That is the lowest of the 11 years on record here.

Latest, FY2025
21.0%
Period ended Dec 31, 2025
Change on a year earlier
0.0 pts
21.0% in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Income Taxes Note (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Federal Statutory Income Tax Rate (%) (%)Year on yearSource
FY2025Dec 31, 202521.0%0.0 ptsForm 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 202421.0%0.0 ptsForm 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 202321.0%0.0 ptsForm 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 202221.0%0.0 ptsForm 10-K (filed 2025-02-14) ↗
FY2021Dec 31, 202121.0%0.0 ptsForm 10-K (filed 2024-02-14) ↗
FY2020Dec 31, 202021.0%0.0 ptsForm 10-K (filed 2023-02-09) ↗
FY2019Dec 31, 201921.0%0.0 ptsForm 10-K (filed 2022-02-16) ↗
FY2018Dec 31, 201821.0%-14.0 ptsForm 10-K (filed 2021-02-09) ↗
FY2017Dec 31, 201735.0%0.0 ptsForm 10-K (filed 2019-02-13) ↗
FY2016Dec 31, 201635.0%0.0 ptsForm 10-K (filed 2019-02-13) ↗
FY2015Dec 31, 201535.0%–Form 10-K (filed 2018-02-13) ↗

Cite this data

StockData. (2026). Amgen U.S. Federal Statutory Income Tax Rate (%), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/etr-statutory

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.